Aggregated China Business Blogs
Guosen Securities maintains Tiger Pharma’s buy rating: the main business continues to recover and non-recurring returns are relatively high
Taiwan braces for Chinese meddling ahead of election
FT Health: Lessons from the Oxfam scandal
Apple iPhone development schedule delayed by China Covid lockdowns – Nikkei
Xiaomi Inks AAC Patent Licensing Deal With Dolby Subsidiary
KKR, CDH To Acquire 9% Of China Modern Dairy
Railway FAI jumps 25.7% to US$6b
HNA seeks to raise $6bn from Hilton Worldwide stake sale
CDH Leads $360M Series A Round In SF Express’ Hive Box Unit
Olympics sponsors duck questions over Beijing 2022 as boycott calls grow